Please assess the completion status of the following clinical trial:

Trial Title: Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* One of the following histologically or cytologically confirmed diagnoses:~  * Stage II-IIIB non-small cell lung cancer (NSCLC)~ * Stage I central NSCLC~    * No peripheral coin lesions~ * Limited stage small cell lung cancer~    * Nonmetastatic disease that is receiving radiotherapy and the target is confined to a single radiotherapy treatment area~* Planning to receive radiotherapy~  * At least 45 Gy to be delivered to the target volume~ * More than 25% of total lung volume to receive \> 20 Gy if receiving radiotherapy alone~PATIENT CHARACTERISTICS:~Age~* 18 and over~Performance status~* Zubrod 0-1~Hematopoietic~* Absolute granulocyte count greater than 1,000/mm\^3~* Platelet count greater than 75,000/mm\^3~* Hemoglobin greater than 9.0 g/dL (transfusion allowed)~Hepatic~* Bilirubin less than 1.5 mg/dL~* Serum glutamate oxaloacetate transaminase (SGOT) less than 2 times normal~Renal~* Blood urea nitrogen (BUN) less than 25 mg/dL~* Creatinine less than 1.6 mg/dL~* Urine protein less than 10 mg/dL~* Urine glucose negative~Cardiovascular~* Systolic blood pressure greater than 110 mm Hg~* Diastolic blood pressure greater than 60 mm Hg~Other~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~* Sodium normal~* Potassium normal~* No collagen vascular disease (e.g., lupus or scleroderma)~  * Rheumatoid arthritis allowed~* No known hypersensitivity to ACE inhibitors~PRIOR CONCURRENT THERAPY:~Biologic therapy~* Not specified~Chemotherapy~* Induction or concurrent chemotherapy allowed either during radiotherapy or during therapy with captopril~* No concurrent methotrexate~Endocrine therapy~* Not specified~Radiotherapy~* See Disease Characteristics~Surgery~* Prior pulmonary lobectomy or segmentectomy allowed~  * No prior pneumonectomy~Other~* No concurrent angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor antagonists for hypertension or congestive heart failure~* No concurrent lithium~* No concurrent procainamide

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Observation (Type: NO_INTERVENTION): Clinical observation
- Captopril (Type: EXPERIMENTAL): Captopril

Based on this trial design, predict the completion outcome and termination type (if applicable).